Page last updated: 2024-10-23

bis(5-amidino-2-benzimidazolyl)methane and Skin Diseases

bis(5-amidino-2-benzimidazolyl)methane has been researched along with Skin Diseases in 1 studies

bis(5-amidino-2-benzimidazolyl)methane: aromatic diamidine which has a significant suppressive effect on the cytopathology & yield of respiratory synctial (RS) virus; RN given refers to parent cpd

Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fish, PV1
Barber, CG1
Brown, DG1
Butt, R1
Collis, MG1
Dickinson, RP1
Henry, BT1
Horne, VA1
Huggins, JP1
King, E1
O'Gara, M1
McCleverty, D1
McIntosh, F1
Phillips, C1
Webster, R1

Other Studies

1 other study available for bis(5-amidino-2-benzimidazolyl)methane and Skin Diseases

ArticleYear
Selective urokinase-type plasminogen activator inhibitors. 4. 1-(7-sulfonamidoisoquinolinyl)guanidines.
    Journal of medicinal chemistry, 2007, May-17, Volume: 50, Issue:10

    Topics: Acute Disease; Animals; Anti-Ulcer Agents; Binding Sites; Chronic Disease; Crystallography, X-Ray; G

2007